Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001835928 | SCV000830828 | uncertain significance | Pontocerebellar hypoplasia type 1A | 2022-10-17 | criteria provided, single submitter | clinical testing | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 282 of the VRK1 protein (p.Ile282Thr). This variant is present in population databases (rs371024271, gnomAD 0.05%). This variant has not been reported in the literature in individuals affected with VRK1-related conditions. ClinVar contains an entry for this variant (Variation ID: 578869). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002442508 | SCV002680609 | uncertain significance | Inborn genetic diseases | 2022-04-26 | criteria provided, single submitter | clinical testing | The p.I282T variant (also known as c.845T>C), located in coding exon 9 of the VRK1 gene, results from a T to C substitution at nucleotide position 845. The isoleucine at codon 282 is replaced by threonine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Natera, |
RCV001835928 | SCV002093701 | uncertain significance | Pontocerebellar hypoplasia type 1A | 2020-07-21 | no assertion criteria provided | clinical testing |